Privium Fund Management B.V.
- SEC CIK
- 0001795097
- Latest filing
- Aug 7, 2026
TSHA holding history
Taysha Gene Therapies, Inc. in every 13F filed by Privium Fund Management B.V., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TSHA overviewAll 13F holders of TSHAFull Q2 2026 holdings
- Shares (Q2 2026)
- 198,900
- Value
- $1.35M
- % of portfolio
- 0.2%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 198,900 | $1.35M | 0.2% | +17,000+9.3% | Added | Holders |
| Q1 2026 | 181,900 | $813.1K | 0.2% | +17,000+10.3% | Added | Holders |
| Q4 2025 | 164,900 | $907.0K | 0.2% | +30,000+22.2% | Added | Holders |
| Q3 2025 | 134,900 | $441.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 134,900 | $315.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 134,900 | $187.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 134,900 | $233.4K | 0.1% | +14,900+12.4% | Added | Holders |
| Q3 2024 | 120,000 | $241.2K | 0.1% | +21,500+21.8% | Added | Holders |
| Q2 2024 | 98,500 | $212.8K | 0.1% | +98,500 | New | Holders |